FDA announces end to Wegovy and Ozempic drug shortages, but it could mean higher prices
The FDA has announced that the shortage of Wegovy and Ozempic, medications used for weight loss and diabetes management, is ...
Novo’s Weight Loss Drugs Removed from FDA Shortage List
The U.S. Food and Drug Administration said on Friday there was no longer a shortage of Novo Nordisk’s popular weight-loss and ...
Speed, cocaine and...Ozempic: Drug dealers add unauthorised weight-loss jabs to their menus as they cash in on fat-busting frenzy
The miracle weight loss drug, sold as injection 'pens' for £170, is appearing on drug menus alongside ADHD medication Ritalin ...
Rolling Out5h
Why altering your GLP-1 dose could backfire on your health
Microdosing glp-1 is gaining traction, but is it safe? Experts warn about compounded semaglutide, reduced efficacy, and ...
Hosted on MSN4h
Ozempic's hidden alcohol benefit uncovered in groundbreaking new trial
A recent clinical study of 48 people with signs of moderate alcohol use disorder showed significantly greater reductions in ...
Dying to be thin? The FDA must regulate counterfeit weight loss drugs, says AG Bonta | Opinion
More than 15.5 million Americans have tried weight loss injectables, but risks are rising with the proliferation of ...
Colorado Public Radio13h
Weight-loss drugs could revolutionize treatment for alcohol addiction
Clinical neuroscientist Joe Schacht offered an overview of the research on weight-loss drugs for alcoholism, other potential ...
Yearslong shortage of popular weight-loss and diabetes drugs is resolved, FDA says
Federal regulators say shortages of Ozempic and Wegovy have been resolved, as supplies of popular diabetes and obesity ...
Utah’s attorney general targets safety issues over weight loss drugs
Utah’s Attorney General Derek Brown signed onto a letter along with attorneys general from 37 other states to ask the Food and Drug Administration to enforce the safety of weight loss drugs.
Lilly, Novo dominance to continue as TD Cowen lifts 2030 GLP-1 sales forecast by 38%
TD Cowen projects that with Eli Lilly (NYSE:LLY) and Novo Nordisk (NVO) continuing their dominance, global sales of the GLP-1 ...
FDA declares end to Wegovy and Ozempic shortage
The Food and Drug Administration announced Friday it had officially declared an end to the nationwide shortage of Ozempic and Wegovy, medications used for diabetes and weight loss. The agency first ...